Illustrative image – not actual.Wyeth Lederle plans to set up a new facility in Goa with a capacity of 1.3 crore tablets per annum at a cost of Rs.54 crore. The new unit is expected to commence operations by March 2002.
Currently, the company has a manufacturing unit at
Ghatkopar in suburban Mumbai, where it manufactures several bulk drugs and drug
intermediaries in addition to formulations.
